Showing results (601-610 of 634) with videos related to
Sort By:
Pageof 64
British Journal of Cancer|March 31, 2017
Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortiumT Goranova, D Ennis, A M Piskorz, et al.The Review of Scientific Instruments|February 3, 2017
Inverse-collimated proton radiography for imaging thin materialsMatthew S Freeman, Jason Allison, Malcolm Andrews, et al.Cell Reports|April 6, 2017
The Mutational Landscape of Circulating Tumor Cells in Multiple MyelomaYuji Mishima, Bruno Paiva, Jiantao Shi, et al.The New England Journal of Medicine|August 9, 2013
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndromeAmi S Bhatt, Samuel S Freeman, Alex F Herrera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancerA G Waks, O Cohen, B Kochupurakkal, et al.Nature|May 4, 2022
Landscape of helper and regulatory antitumour CD4+ T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.Ecology and Evolution|January 22, 2025
The Influence of Migration Timing and Local Conditions on Reproductive Timing in Arctic-Breeding BirdsW B English, B Lagassé, S Brown, et al.Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.The Lancet. Haematology|March 1, 2023
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort studyAnnie Cowan, Federico Ferrari, Samuel S Freeman, et al.Pageof 64